Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how the National Cancer Plan will support people with secondary breast cancer.

The National Cancer Plan, published 4 February 2026, will transform outcomes for people with secondary breast cancer.

The National Health Service is piloting the use of self-referral breast cancer pathways to streamline diagnostic pathways using the NHS App and NHS 111 online service. This is in addition to the Government’s commitment for the NHS to deliver 9.5 million additional tests by 2029 through a £2.3 billion investment in diagnostics. We are also ensuring as many community diagnostic centres as possible are fully operational and open 12 hours a day, seven days a week.

To improve the diagnosis of breast cancer, the NHS will harness 'circulating tumour DNA' tests for breast cancer, which can pick up relapse months earlier. This will accelerate clinical decisions and allow patients to start the most effective treatment faster.

The NHS will monitor the emerging evidence from the BRAID trial, which aims to determine whether additional imaging with one of several types of scans, is helpful in diagnosing breast cancer in women with dense breast tissue. This will target screening programmes at women who are at greater risk of cancer.

The NHS is also improving the experience of those with a cancer diagnosis. Every patient diagnosed with cancer will be supported through a full neighbourhood-level personalised care package, covering mental and physical health as well as any practical or financial concerns. For people with secondary breast cancer, this will be a step forward in building care around them, their needs, their lives, and their families.

We will harness data, as we begin counting metastatic disease, starting with breast cancer, so that people living with incurable cancer are properly recognised and better supported.

Through these National Cancer Plan actions, we will ensure that people with secondary breast cancer have faster diagnoses and treatment, access to the latest treatments and technology, and high-quality support throughout their journey, while we work to drive up this country’s cancer survival rates.